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1. Introduction 
Cardiac arrhythmias result from the confluence of structural and functional changes in the 
heart and genetic predisposition, reflecting an interaction between a susceptible substrate 
(e.g. an anatomically defined circuit, a myocardial scar, fibrosis or a monogenic arrhythmia 
syndrome) and a specific electrophysiological triggering event. Such triggered activities 
arises from delayed afterdepolarizations (DADs) or early afterdepolarizations (EADs), in 
which action potential prolongation and aberrant Ca2+ fluxes are a recurrent theme. 
Ca2+ channels in cardiomyocytes provide the main influx pathway for Ca2+. Three types of 
high threshold Ca2+ channels are expressed in heart: two L-type channels, Cav1.2 and Cav1.3 
and a P-type channel, Cav2.1. The Cav2.1 channel protein is expressed at a very low level the 
in heart (Starr et al., 1991) while Cav1.3 is mainly expressed in fetal hearts and only in adult 
sinoatrial and atrioventricular nodes and atrial tissues of adult (Lipscombe et al., 2004; Qu et 
al., 2005). We will focus attention on the Cav1.2 L-type Ca2+ channel (LTCC) which is the 
main player in electrical activity and excitation-contraction coupling (EC coupling) in the 
ventricular cardiomyocyte. 
The LTCC of cardiomyocytes is a complex multimeric molecular sarcolemmal ensemble that 
during an action potential (AP) allows Ca2+ to flow down its electrochemical gradient into 
the cardiac cell. LTCCs are mostly localized in the transverse tubular system of 
cardiomyocytes (Wibo et al., 1991; Kawai et al., 1999; Brette et al., 2004). Activation of LTCC 
generates a Ca2+ current (ICaL) through the sarcolemma large enough to be involved in AP 
overshoot and in the control of AP duration (APD) in different cardiac cells types (Bers, 
2001). ICaL serves as a trigger for Ca2+ release from the sarcoplasmic reticulum (SR) during 
the excitation-contraction coupling by a mechanism known as calcium-induced calcium 
release (CICR, Fabiato & Fabiato, 1975; Bers, 2001). LTCC activation can also play a role in 
transcription mechanisms in cardiomyocytes (Atar et al., 1995; Brette et al., 2006). Several 
hormones and neuromediators modulate the activity of LTCC via complex intracellular 
signaling pathways and, as well, several intracellular molecules and the cytoskeleton can 
influence LTCC activity (Benitah et al., 2010). However, intracellular Ca2+ concentration is 
strictly controlled in normal cells by different mechanisms (Bers, 2001) since a Ca2+ overload 
can have deleterious effects including arrhythmias and myocardial remodeling via a genetic 
reprogramming of the cardiac cell (Benitah et al., 2003). 
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2. Macromolecular structure 
The typical structure of LTCC in ventricular cardiomyocytes is a macromolecular 
multimeric complex consisting of a ~240 kDa pore-forming unit ǂ1C (encoded by the 
CACNA1C gene) and two auxiliary (modulator) subunits: an intracellular ǃ subunit (mainly 
ǃ2A, encoded by the CACNB2A gene) and the dimer ǂ2ǅ subunit (mainly ǂ2ǅ-1, encoded by 
the CACNA2D1 gene) in a 1:1:1 ratio (Catterall et al., 2005). The ǂ1C subunit consists of four 
homologous repeating motifs (I–IV), each one composed of six membrane-spanning ǂ-
helices (S1 to S6) linked by variable extracellular and cytoplasmic loops (linkers). This 
subunit contains all the necessary structures to allow the channel to gate (activation and 
inactivation) and confers the Ca2+ selectivity as well as the electrophysiological and 
pharmacological properties of the LTCC (Takahashi & Catterall, 1987; Catterall, 2000; 
Carafoli et al., 2001; Lacinová & Hoffmann, 2001; Bodi et al., 2005; Lacinova & Hofmann, 
2005; Brette et al., 2006; Benitah et al., 2010). However, more native LTCC properties can be 
achieved when all three subunits are present (Lacinová & Hoffmann, 2001; Lacinova & 
Hofmann, 2005; Benitah et al., 2010). The ǃ2A subunit seems to be involved in membrane 
targeting of ǂ1C and influence LTCC inactivation (Bodi et al., 2005; Lacinova & Hofmann, 
2005; Brette et al., 2006). Its structure reveals a module of two interacting domains, a Src 
homology 3 (SH3) domain and a Guanylate Kinase (GK) domain (Chen et al., 2004; Bodi et 
al., 2005). It was initially believed that its conserved sequence, BID (Beta Interaction 
Domain), interacted directly with the Alpha Interaction Domain (AID) within the 
intracellular loop between domains I and II of the ǂ1C subunit (De Waard et al., 1996; 
Arikkath & Campbell, 2003). However, recent data indicate that BID is largely buried in the 
Cavǃ core and is unavailable for protein-protein interactions (Chen et al., 2004; Van Petegem 
et al., 2004). The AID is bound in a hydrophobic groove (ǂ-binding pocket, ABP) in the GK 
domain and positions the ǃ-subunit near the intracellular pore-lining segment I6 (which is 
important in Ca2+ channel inactivation) thus providing evidence that Cavǃ influence Ca2+ 
channel gating by direct modulation of this segment (Van Petegem et al., 2004). Although 
the BID does not participate directly in binding the ǂ1C subunit, structural integrity and 
bridging of the SH3 and GK domains are greatly influenced by BID. The ǂ2ǅ-1 subunit 
seems to be involved in targeting (or stabilization) of the ǂ1C to the sarcolemma (Lacinová & 
Hoffmann, 2001; Lacinova & Hofmann, 2005; Brette et al., 2006; Benitah et al., 2010) and 
could confer more native LTCC properties. The ǅ subunit is composed of a single 
transmembrane segment with a very short intracellular C-term and links by disulphide 
bonds the ǂ2 subunit that is entirely extracellular (Davies et al., 2007). The ǂ2 subunit 
contains a Von Willebrand factor A domain (VWA) that has a metal-ion-dependent 
adhesion site that seems to be key in trafficking the ǂ1C subunit to the membrane (Canti et 
al., 2005). 
3. Biophysics of the cardiac L-type Ca
2+
 channel 
3.1 Selectivity and permeation 
The cardiac LTCC is a multi-ion pore in which a Ca2+ ion bound to a high affinity site can be 
repelled by a second Ca2+ ion entering the pore thus allowing selectivity with high ionic flux 
(Hess & Tsien, 1984). The LTCC pore exhibits two different affinities for Ca2+: a KD ~ 1 μM 
for Ca2+ block of monovalent current through the channel and a KD ~ 10-14 mM for 
saturation of divalent current (which can be lower if surface charge screening is taken into 
account at high divalent concentrations), suggesting the existence of two Ca2+ binding sites 
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within the channel’s pore (Almers & McCleskey, 1984; Hess & Tsien, 1984). In the absence of 
Ca2+ other ions can pass the channel and unitary conductance measurements gave the 
following sequence Ca2+ < Ba2+ < Li+ < Na+ < K+ < Cs+ (Hess et al., 1986). Four glutamate 
residues, one in each of the four P-loops of the LTCC (the EEEE locus), are important for 
channel selectivity (Tang et al., 1993; Yang et al., 1993). The current view of the selectivity 
filter considers that the EEEE locus is physically flexible (Sather & McCleskey, 2003). Some 
recent results suggest that an EEEE locus is not enough to explain selectivity and 
permeation in LTCC and other high voltage activated Ca2+ channels. A set of non conserved 
(channel specific) charged residues (Divalent Cation Selection or DCS locus) located in the 
upper half of the channel (pointing toward the pore) could form a second Ca2+ binding site 
important in defining a Ca2+ permeability profile. It was proposed that the number of 
charged residues in the DCS locus is critical for Ca2+ binding. In the cardiac LTCC the DCS 
locus contains three negative charges (DSED) that seem to be important for the high Ba2+ 
conductance (Cens et al., 2007). 
3.2 Activation, inactivation and reactivation of LTCC 
In a ventricular cardiomyocyte at rest (resting potential ~ -80 mV) there is a transmembrane 
Ca2+ concentration gradient (~ 2 mM outside, ~ 100 nM inside) that generates a huge driving 
force (electrochemical gradient) for Ca2+ that tends to move it into the cell. Activation of 
LTCC allows Ca2+ to enter the cardiomyocyte during the AP and constitutes the major Ca2+ 
entry pathway. With a threshold at  -40 mV (or slightly positive to), activation of ICaL is fast 
with a time constant of 2-3 ms and time-to peak inward current ranging around 4-5 ms or 
less at the membrane potentials at which maximal inward current occurs (0 to +10 mV), and 
even faster at higher depolarizations (McDonald et al., 1994; Bers, 2001). Similar to Na+ 
channels, LTCC inactivate but with a much slower inactivation time course. With Ca2+ as 
charge carrier, ICaL inactivation is usually a biexponential process with an “U-shaped” 
voltage-dependence. Minimal values for time constants of 4 to 10 ms (τfast) and 40 to 60 ms 
(τslow) occur at around 0 and +10 mV depending on cardiomyocyte type (McDonald et al., 
1994; Bers, 2001). Deactivation of peak ICaL after a short depolarizing pulse and 
repolarization to a negative holding potential is fast with a time constant ranging between 
0.2 and 0.5 ms (Josephson et al., 1984; Cohen et al., 1992). However, it can be slower in rat 
cardiomyocytes (~1 ms) (Richard et al., 1993). 
3.2.1 Current-to-Voltage relationship 
Current-to-voltage relationship for ICaL is bell-shaped with a threshold around -40 or -30 mV 
and a peak inward current at 0 (or +10 mV); it is almost linear at positive potentials and 
reverses around +60 to +70 mV at normal Ca2+ concentrations. At potentials beyond its 
reversal, ICaL exhibits some inward going rectification (McDonald et al., 1994; Bers, 2001). 
Whole cell ICaL can be roughly described by a Hodgkin-Huxley formalism considering that 
ICaL = GCaL⋅d∞ f∞ (Vm − VCa) 
where GCaL is the maximal Ca2+ conductance, d∞ is the activation gate variable, f∞ the 
inactivation gate variable, Vm is the membrane potential and VCa is the Ca2+ reversal 
potential (Luo & Rudy, 1994). Since ICaL inactivation is both voltage- and Ca2+-dependent 
(see below), the formalism can be more complex and could include a variable related to the 
Ca2+-dependent inactivation (CDI) process (Hirano & Hiraoka, 2003; Findlay et al., 2008). 
However, since the Hodgkin-Huxley formalism does not represent kinetic states of the ion 
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channel, single channel-based Markov models could be more useful to fully describe 
coupling between kinetic gating transitions and molecular interactions in LTCC (Faber et al., 
2007). At the single channel level, current-to-voltage relationship for LTCC is essentially 
ohmic over the whole potential range with some inward rectification near the reversal 
potential (McDonald et al., 1994). Since the single channel current iCaL can be described as 
iCaL = ǄCa (Vm − VCa) 
where ǄCa is the unitary conductance, the relationship between whole cell ICaL and iCaL is 
ICaL = NPo iCaL = NPo ǄCa (Vm − VCa) 
where N is the total number of functional channels and Po the probability that a channel is 
open. 
Unitary conductance of LTCC is 3-5 pS when Ca2+ is the charge carrier and 15 - 25 pS with 
Ba2+ as charge carrier (McDonald et al., 1994; Bers, 2001; Guia et al., 2001). However, 
subconductance levels of 50% to 70% of the major conductance have been also demonstrated 
(McDonald et al., 1994). On depolarization LTCC activity can vary between different modes: 
gating mode 0 (or “null mode”) in which the channel is not available to open; gating mode 1 
(or “normal”) consisting of short bursts of brief openings and closings and gating mode 2 
(with high Po) in which the channel show long openings interrupted by short closings. This 
gating mode 2 is induced by phosphorylation, “Ca2+ channel agonists” (such as BAY K 8644) 
or strong depolarizations (Pietrobon & Hess, 1990; McDonald et al., 1994). 
3.2.2 Voltage-dependence of activation and inactivation 
Steady-state activation of ICaL (d∞) has a sigmoidal relationship with the membrane potential 
with a half-activation potential around -15 mV. The relationship for the inactivation variable 
(f∞; availability) is more complex since for potentials from -80 to 0 mV it is sigmoidal with a 
half-inactivation potential around -35 mV; however an “overshoot” can often be seen at 
potentials negative to -50 mV in cells clamped at negative holding potentials (> -80 mV). 
Other singularities of the availability curve of ICaL are that f∞ rarely attains a zero value but a 
minimum between 0 and +10 mV and that the curve bends up at potentials positive to +10 
mV, a phenomenon that is related to the CDI of ICaL (Mentrard et al., 1984). These 
characteristics d∞ and f∞ are consistently seen in cardiomyocytes from different species 
including humans (McDonald et al., 1994; Bers, 2001; Treinys & Jurevicius, 2008; Benitah et 
al., 2010). 
3.2.3 Voltage- and Ca
2+
-dependent inactivation of LTCC 
Time-dependent inactivation of ICaL during depolarization is both voltage- and Ca2+-
dependent (Kass & Sanguinetti, 1984; Mentrard et al., 1984; Lee et al., 1985; Hadley & Hume, 
1987). A very slow inactivation has also been described in the heart including human 
ventricular myocytes (Schouten & Morad, 1989; Benitah et al., 1992). CDI can be considered 
as the result of a two-component process, one due to Ca2+ ions passing through the channel 
and another due to Ca2+ release from the SR in the vicinity of the LTCC (Imredy & Yue, 
1992; Richard et al., 2006; Faber et al., 2007). CDI can be easily shown up by using Ba2+ 
instead of Ca2+ as charge carrier which markedly prolonged LTCC inactivation time course. 
An increase in current amplitude is also seen since the LTCC has less affinity for Ba2+ than 
for Ca2+ (Hess et al., 1986). It is generally believed that under this condition, LTCC 
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inactivation is essentially controlled by a voltage-dependent inactivation mechanism (VDI). 
However, this paradigm has been called into question since it has been well demonstrated 
that Ba2+ can induce ion (or current) -dependent inactivation (Markwardt & Nilius, 1988; 
Ferreira et al., 1997; Ferreira et al., 2003) and thus the “apparent VDI” with Ba2+ as charge 
carrier also shows fast and slow components. Evidences exist that VDI can also have fast 
and slow components (Hering et al., 2000; Ferreira et al., 2003; Findlay, 2004). The situation 
could be even more complicated since, at least for N-type Ca2+ channels, the permeant ion 
could interact in a complex way with the voltage sensor (Shirokov, 1999). 
The relative contribution of CDI to total inactivation of ICaL is still under dispute. It is 
commonly accepted that the fast inactivation phase of ICaL represents the CDI component 
(Findlay, 2004). However, it has been shown that the fast inactivation time constant of ICaL of 
rat ventricular cardiomyocytes was “unexpectedly” slowed down after ICaL was increased by 
ǃ-adrenergic stimulation, as well as after manipulations not involving CDI (Alvarez et al., 
2004; Haase et al., 2005; Alvarez et al., 2010). This makes difficult to ascertain which one of CDI 
or fast VDI predominates in the fast inactivation phase of ICaL with Ca2+ as charge carrier. 
Nevertheless, it has been suggested that VDI could be more important under control 
conditions and that after ǃ-adrenergic stimulation, CDI becomes the main inactivation 
mechanism due to a slow down of VDI (Findlay, 2004). It should be noted that CDI could be 
visualized as a “Ca2+-dependent brake for a pre-existing voltage-dependent inactivation” 
based on the conserved regulation of both VDI and CDI by the auxiliary ǃ-subunit, and that 
the I-II intracellular loop, essential for VDI, could also play a role in CDI (Cens et al., 1999; 
Cens et al., 2006). The precise mechanisms underlying CDI are not completely well defined. 
However, a general picture emerged in which in the presence of Ca2+ (entering through the 
LTCC or released from the SR) a calmodulin (CaM) molecule binds to the C-terminal tail of the 
ǂ1C subunit to promote CDI. CaM binds to two segments (LA and IQ), in a Ca2+-dependent 
manner (Xiong et al., 2005) and it has been shown that the amino acid sequence of the IQ 
region in the ǂ1C subunit is critical for CaM binding and CDI (Ohrtman et al., 2008). Several 
other structures seem to be involved in CDI such as an EF-hand locus in the C-terminus of ǂ1C 
subunit (Peterson et al., 2000), the Cavǃ subunit (Zhang et al., 2005), the N-terminus of the ǂ1C 
subunit, the I-II intracellular linker (Pitt et al., 2001; Erickson et al., 2003; Kobrinsky et al., 2005) 
and the pore region involved in slow inactivation (Shi & Soldatov, 2002). 
3.2.4 Reactivation 
Reactivation (removal of inactivation) of LTCC has been described as a mono or 
biexponential process, however, the time for half reactivation (t50) can be considered as a 
reliable parameter and has been reported to be in the range of 70-100 ms in cardiomyocytes 
clamped at negative holding potentials (-80 mV or more negative) and an overshoot at short 
coupling intervals is often seen. At more depolarized holding potentials, t50 can be notably 
increased and the overshoot disappears (Argibay et al., 1988; Tseng, 1988; Schouten & 
Morad, 1989; Alvarez & Vassort, 1992). A voltage-dependent transition into a closed 
available state and/or reopenings from the inactivated state could explain in part the 
reactivation of LTCC (Jones, 1991; Slesinger & Lansman, 1991). However, reactivation of 
LTCC is a more complex phenomenon since it is Ca2+-dependent (Argibay et al., 1988; 
Tseng, 1988) and thus related to CDI. The overshoot in ICaL reactivation could be of 
physiological relevance since it is, at least in part, related to the well-known increase in 
premature (extrasystolic) APD in well polarized cardiomyocytes but not in partially 
depolarized ones (Hiraoka & Sano, 1976). 
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3.3 Facilitation of LTCC 
The overshoots seen in the availability and reactivation curves of ICaL are both a 
manifestation of a “facilitation” phenomenon of LTCC. In both cases an increase in τfast is 
commonly observed and both seem to be related to the pacing-dependent (staircase) 
facilitation of ICaL (Lee, 1987). However, the “overshoots” and the staircase phenomena 
could be dependent on the basal ICaL density disappearing at higher current densities 
(Argibay et al., 1988; Alvarez & Vassort, 1992; Piot et al., 1996). Facilitation of LTCC has been 
more extensively studied by stimulating cardiomyocytes at high rates after a rest period or 
by applying prepulses of moderate and high amplitude (Richard et al., 2006). At negative 
holding potentials (> -80 mV) the frequency-dependent changes in ICaL amplitude upon 
stimulation can be variable: significant (Lee, 1987), modest or absent (Piot et al., 1996; 
Delgado et al., 1999) and even modestly decrease (Argibay et al., 1988; Alvarez & Vassort, 
1992; Alvarez et al., 2004). However, an increase in τfast has been consistently reported in 
these conditions, resulting, independently of what happens with ICaL amplitude, in a 
significant increase in Ca2+ influx (Delgado et al., 1999). The mechanism of this “Ca2+-
dependent facilitation” (CDF) or potentiation seems to be related to a negative feedback 
involving less CDI at frequencies at which Ca2+ load and release from the SR are decreased 
(Delgado et al., 1999). This phenomenon has often been related to phosphorylation by cyclic 
AMP-dependent protein kinase (Tiaho et al., 1994; Piot et al., 1996) although there are also 
reports that ǃ-adrenergic stimulation significantly diminished ICaL facilitation (Zygmunt & 
Maylie, 1990; Delgado et al., 1999; Alvarez et al., 2004). Disruption of the interaction between 
ǂ1C and ǃ2A subunits also abolished CDF (Alvarez et al., 2004). In this sense, this 
phenomenon is still far to be completely understood. CDF also involves CaM and the 
Ca2+/CaM kinase II (CaMKII). Similar to CDI, the CDF requires the binding of CaM to the 
IQ motif located in the ǂ1C C-terminus but to a structural frame different to that involved in 
CDI (Zuhlke et al., 1999). Activation of CaMKII by Ca2+ entry or release from the SR is also 
involved in ICaL facilitation (Anderson et al., 1994; Yuan & Bers, 1994; Anderson, 2004). More 
recently phosphorylation of ǃ2A has been reported to be critical for CaMKII-dependent ICaL 
facilitation (Grueter et al., 2006). 
Similar to frequency-dependent facilitation, prepulse-induced facilitation of ICaL is 
characterized by an increase in τfast (Barrere-Lemaire et al., 2000) and its underlying 
mechanism seems to involve a negative feedback on LTCC related to CDI as discussed 
above (Guo & Duff, 2003) and a positive feedback on LTCC following CaMKII activation by 
membrane potential and Ca2+ entry (Xiao et al., 1994). 
3.4 LTCC “window” current 
Activation and inactivation (availability) curves overlap at membrane potentials between 
the threshold for ICaL at -40 to potentials of 0 or +10 mV thus defining a “window” Ca2+ 
current (d∞.f∞ > 0) in the plateau range of the cardiac AP. The peak window current (which 
is proportional to d∞.f∞) is between -25 and -20 mV and could be as large as 10% of maximal 
ICaL (McDonald et al., 1994). Its existence has been verified in whole cell recordings (Hirano 
et al., 1992; McDonald et al., 1994). Within this window LTCC channels can cycle between 
closed, open and inactivated states but a transition again to the closed state and reopenings 
are possible before inactivating again (Shorofsky & January, 1992). Such reopenings have 
been clearly demonstrated in single channel recordings (Shorofsky & January, 1992; 
McDonald et al., 1994) and constitute the underlying mechanism for the EAD (January et al., 
1988). EADs are more frequently observed at low rates when the APD is increased and 
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during interventions that increase ICaL (e.g. after activation of ǃ-adrenergic receptors). They 
are supposed to underlie the cellular mechanism of “Torsades de Pointes” (TdP) in long QT 
syndromes (Napolitano & Antzelevitch, 2011). Transient K+ outward current (Ito) 
reactivation at low rates could contribute to generation of EADs since it drives the 
membrane (plateau) potential to more negative “take off” potentials and warrants higher 
peak amplitude of EADs (January et al., 1988). ǃ-adrenergic stimulation increases ICaL and 
shifts the window current to more negative potentials due to an increase in channel’s Po at 
more negative potentials (hyperpolarizing shifts in d∞) and a shift of f∞ to more 
hyperpolarized potentials (McDonald et al., 1994) thus favoring the appearance of EADs. It 
is to be noted that, at these membrane potentials, the fast Na+ current (INa) and Ito are 
inactivated, the inward rectifier current IK1 is decreased and outward rectifier currents are 
just activating. As a result the total membrane resistance is increased (Weidmann, 1951) thus 
making the membrane space constant high enough to guarantee a rather high safety margin 
for the slow response to be conducted for a given ICaL density. 
3.4.1 A note on “EADs” recorded in multicellular cardiac preparations 
It is possible that in some cases EADs recorded in multicellular cardiac preparations represent 
a reentry from a distant site rather than a true EAD arising from the recording site. In any case, 
the mechanism underlying this activity is the same as the previously described for EAD. This 
reentry mechanism, at these short coupling intervals (during the AP plateau) is due to “slow 
response” APs that can be conducted with a large enough safety margin and are due to the 
activation of LTCC (Cranefield, 1975). The biophysical properties of LTCC described above, 
can fully account for the conducted slow response APs in partially depolarized cells. Under 
several pathological conditions these slow responses can be conducted and are at the origin of 
reentry, for example in depressed fibres in ischemia (Cranefield, 1975) since the slow response 
APs are rather resistant to hypoxia (Alvarez et al., 1981), in TdP associated to long QT 
syndromes (Antzelevitch & Burashnikov, 2001) (see below) or during the verapamil-sensitive 
reentrant intranodal tachycardia involving the AV node (Wellens et al., 1977). 
3.4.2 A role for a second window current? 
The characteristics of the activation and inactivation curves of ICaL could predict the 
existence of a “second window” current at potentials positive to +10 mV since at these 
values, the product d∞.f∞ is > 0. Whether the overlap between d∞ (=1) and the increasing f∞ at 
positive prepulse potentials could represent a true “secondary” window current or not is 
debatable, but it is clear that after these prepulse potentials LTCCs recover from inactivation 
and reopen in a sort of “facilitation” (Pietrobon & Hess, 1990). Nonetheless, the 
physiological (or physiopathological) relevance of this window current is uncertain since at 
these membrane potentials the fast INa is the main depolarizing current and physiologically 
membrane potentials over +40 mV never exist. This property, however, has been important 
for the characterization of the CDI of LTCC in cardiac cells (Mentrard et al., 1984). 
4. Role of ICaL in the cardiac arrythmogenesis associated to acquired 
pathophysiological states 
4.1 Myocardial ischemia and ventricular fibrillation 
Ventricular fibrillation (VF) and myocardial ischemia are inseparable. In general terms, 
myocardial ischemia is defined as disequilibrium between myocardial oxygen demand 
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versus supply, which episodes can trigger serious and fatal arrhythmic events. Thus, in the 
clinical setting around 80% of all sudden cardiac deaths (SCD) are due to myocardial 
ischemia. The most common sequence of events leading SCD appears to be the degeneration 
of ventricular tachycardia (VT) into ventricular fibrillation (VF) (Rubart & Zipes, 2005). VF is 
thought as a disorganized cardiac activation in which electrical waves propagate through 
the ventricles haphazardly and unpredictably (Jalife, 2000). The last consequence of this 
disorganized process is strong alteration in the adequate contractions of the ventricles that 
fail to eject blood effectively as a consequence of a strong electrical dysfunction, which is 
detected in the heart even during the first minutes after acute myocardial ischemia (usually 
lasting for 30 min) where abundant arrhythmogenesis is detected. During acute ischemia, in 
the border zone between the ischemic and normal tissue the excitability is increased 
resulting in spontaneous activation of Purkinje fibers initiating VT. During reperfusion the 
rapid inhomogeneous improvement in tissue excitability contributes to arrhythmogenesis 
again (Opthof et al., 1993; Luqman et al., 2007). 
At intracellular level, an important ionic imbalance occurs during myocardial ischemia. This 
electrophysiological imbalance is characterized by the opening of ATP-sensitive potassium 
channels (IKATP) and causes acidosis and hypoxia of myocardial cells together with an 
aberrant intracellular Ca2+ handling that is determinant to trigger arrhythmias. Because ICaL 
constitutes the first trigger for the EC coupling necessary for each beat in the heart, a lot of 
attention has been focused in the involvement of ICaL in the conversion of VT to VF. With 
myocardial ischemia, the abrupt cessation of blood flow provokes a new distribution of a 
number of ions. The abnormal increase in the intracellular Na+ concentration ([Na+]i) 
consequently results in an increase in the intracellular Ca2+ concentration ([Ca2+]i) due to an 
increase in the Ca2+ influx via the Na+/Ca2+ exchanger (NCX) working in the reverse 
manner and also via depolarization-activated LTCCs. These events induce cellular Ca2+ 
overload (as a consequence of cellular Na+ overload) favoring the presence of spontaneous 
(non-voltage dependent) diastolic Ca2+ release as Ca2+ waves that induce depolarization of 
myocyte membrane triggering DAD and finally DAD-related arrhythmias (Schlotthauer & 
Bers, 2000). The presence of DADs also can trigger abnormal electrical activity with the 
wavebreak causing VF (Koretsune & Marban, 1989; Lakatta & Guarnieri, 1993). 
It is important to point out that cardiac ischemia is also characterized by a significant 
increase in circulating and tissue cathecholamine levels, which increase the probability of 
VT and SCD (Dorian, 2005). In the presence of ǃ-adrenergic receptor (ǃ-AR) stimulation and 
hypoxic conditions, a significant increase in Ca2+ influx through ICaL is able to prolong APD 
and also triggers EADs (Gaur et al., 2009), which in ventricular myocytes appear not to be 
due to spontaneous regional increase in [Ca2+]i or propagating Ca2+ waves. These results can 
be explained by the increase in the sensitivity of LTCC due to changes in gating properties 
by the modification of the phosphorylated state or by the modification of thiol groups of the 
channel, since the presence of dithiothreitol or catalase mimics the effect of acute hypoxia on 
ICaL (Hool, 2000; Hool & Arthur, 2002; Tanskanen et al., 2005). Alterations in ICaL have been 
also detected in simulated experimental ischemic-like conditions in single pacemaker cells 
isolated from the rabbit sinoatrial node (SAN). In contrast to ventricular myocytes, ICaL is 
declined under metabolic inhibition or ischemic conditions in SAN cells (Vinogradova et al., 
2000; Ju & Allen, 2003). However, it has been reported that in vitro ischemic conditions 
enhanced ICaL significantly at potentials between -30 and +30 mV suggesting that the greater 
ICaL could account for a 6 mV increase in the AP overshoot (Du & Nathan, 2007a). This is 
related to an increase in the GCaL and a positive shift of the f∞ curve and reduction of 
inactivation, likely due to a H+- increased of ICaL (Du & Nathan, 2007b). 
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Torsades de Pointes (TdP) is a polymorphic type of VT also associated to acquired QT 
prolongation and maintained bradycardia that potentially leads to SCD (Jackman et al., 
1988). Several studies carried out in rabbits and dogs prone to spontaneous TdP as a 
consequence of the chronic atrioventricular block (AVB) showed important alterations in the 
control of Ca2+ (Sipido et al., 2000; Antoons et al., 2007; Qi et al., 2009). For example, AVB in 
dogs resulted in an increase in the SR Ca2+ content which improved Ca2+ release from SR as 
Ca2+ transients (Sipido et al., 2000). Although, the overall density-voltage relationship of ICaL 
is unchanged, a depolarizing shift in the f∞ curve resulted in an increased window current 
(Antoons et al., 2007). The CaM activation of CaMKII has been proposed to underlie this 
effect, as well the induced EADs (Qi et al., 2009).  
4.2 Atrial fibrillation 
Among supraventricular tachyarrhythmias, atrial fibrillation (AF) is the most common. Its 
prevalence is considerably increased with age, and thus AF is now classified as an epidemic 
(Lip et al., 2007). The cellular and molecular bases of AF electrophysiology and the 
underlying mechanisms have been extensively investigated (Hatem et al., 2010). The 
definition of the latest report of the American College of Cardiology/American Heart 
Association/European Society of Cardiology (ACC/AHA/ESC) guidelines for AF is limited 
to a description of the pattern of irregular atrial waveforms on the electrocardiogram (ECG) 
as a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with 
a replacement of consistent P waves by rapid oscillations or fibrillatory waves (Fuster et al., 
2011). At the cellular level, AF is characterized by strong alterations in the cardiac 
electrophysiology. The repolarizing currents such as Ito is almost suppressed and the 
voltage-gated K+ current (IKur) is decreased by around 50% (Le Grand et al., 1994; Van 
Wagoner et al., 1997). While upon the onset of AF, an increase in the intracellular Ca2+ load 
is observed, in persistent AF the intracellular Ca2+ load is restored to normal levels. There is 
a consensus in the drastic reduction in ICaL (around 70%) that is observed during 
experimental and clinical AF. Because this current is the main depolarizing current that 
activates during plateau phase of the AP, its reduction contributes greatly to the shortening 
of the AP, reducing atrial effective refractory period with a loss of physiological rate 
adaptation and finally favouring the formation of re-entrant circuits during AF (Le Grand et 
al., 1994; Van Wagoner et al., 1997; Yue et al., 1997). Several authors have postulated a 
significant decrease in the number of Ca2+ channels subunits Cav1.2 associated with AF 
(Brundel et al., 2001; Shinagawa et al., 2003). In fact, experiments carried out in cultured 
adult canine atrial myocytes subjected to in vitro model of atrial tachycardia by continuous 
tachypacing have demonstrated that during the first hours of pacing exist a Ca2+ overload 
involved in the activation of the phosphatase (PP) calcineurin (Cn) that allows the 
translocation of the transcriptor factor NFAT into the nucleus. This rapid Ca2+ overload 
induces the activation of the Ca2+-dependent CaM-Cn-NFAT system to cause the 
transcriptional downregulation of ǂ1C subunit mRNA expression and also in the levels of 
Cav1.2 protein expression that is observed from 8 hours of pacing (Qi et al., 2008). These 
results are in conflict with others demonstrating no changes in mRNA and protein levels of 
the pore-forming ǂ1C and the regulatory ǃ2A subunits in atrial myocardium from patients 
with chronic AF (Schotten et al., 2003). Nevertheless, the reduction of ICaL can also be the 
result of changes in gating properties of the channel (Bodi et al., 2005), due to alterations in 
the phosphorylation state of the LTCC. Indeed, it has been observed that the maximum of 
the current-voltage relationship of ICaL is rightward shifted to more positive potentials in AF, 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
130 
suggesting phosphorylation-dependent changes in the channel regulation more than 
changes in its expression (Christ et al., 2004). In addition, it has been also described a high 
sensitivity of ICaL to ǃ-adrenergic agonists during AF, suggesting that LTCCs are in a 
dephosphorylated and silent state (Boixel et al., 2001; Schotten et al., 2003; Dinanian et al., 
2008; Hatem et al., 2010). Moreover, the activity of CaMKII is increased in AF (Neef et al., 
2010). However, increased CaMKII activity in AF seems to be offset by an increased PP 
activity, because CaMKII inhibitor KN-93 reduce ICaL in control cells, while it did not affect 
ICaL in AF cells (Greiser et al., 2007; Greiser et al., 2011). Moreover, the PP inhibitor, okadaic 
acid, increased ICaL to almost normal levels in human atrial myocytes from AF patients 
(Christ et al., 2004; Greiser et al., 2011). In conclusion, in AF the ratio between protein 
kinase/phosphatase is altered in favor of increased PP activity, suggesting that the basal 
phosphorylation of the Ca2+ channel is reduced which induces lower basal ICaL activity.  
It seems clear that the abnormal atrial electrical remodeling associated to AF contributes to 
perpetuation of the arrhythmia and has profound effects on intracellular Ca2+ handling 
(Greiser et al., 2011). Contractile force of atrial tissue strips from patients with AF is also 
reduced around 75% and exposure to high extracellular Ca2+ concentration is able to restore 
atrial functions (Schotten et al., 2001; Schotten et al., 2004). In a sheep model of persistent 
AF, even with only a slight reduction in ICaL (around 24%), its efficiency to highly reduced 
CICR (Lenaerts et al., 2009). In the presence of Ca2+ chelators, ICaL was unchanged in AF 
conditions while it is increased in control cells. These results are well-matched with a 
possible reduction in the CDI of ICaL. 
4.3 Cardiac hypertrophy and heart failure 
Following a pathological stress, the heart can adapt by developing cardiac hypertrophy, 
which improves contractile force as an adaptative mechanism to meet the new body 
demands. In this case, the cardiac hypertrophy is “compensated”, as in physiologic cardiac 
hypertrophy by exercise or during the pregnancy. When the stimulus is prolonged, cardiac 
hypertrophy can “decompensate” toward heart failure (HF) with compromised pump 
function (Benitah et al., 2010). One of the best documented changes in hypertrophy and HF, 
both in animal models and in humans, is the prolongation of the AP, which is highly 
significant in the production of ventricular arrhythmias. Important abnormalities of 
intracellular Ca2+ handling has been showed in the hypertrophic and failing myocytes: 
reduced SERCA function, enhanced NCX function and enhanced SR Ca2+ leak contributing 
to the reduced SR Ca2+ load (Bers et al., 2003). It is also well known that changes in ICaL in the 
hypertrophic and failing heart can also contribute to the electrical instability. Although the 
different degrees in the severity of pathological stresses as well as the variability among 
different models appear to influence the regulation of ICaL, the amplitude of ICaL is increased 
in hypertrophied and failing myocytes while its density (normalized to cell capacitance, as 
an indirect measure of cell surface) is unchanged (Benitah et al., 2002a; Benitah et al., 2003; 
Song et al., 2005; Loyer et al., 2008). In an early analysis of a pressure-overloaded cardiac 
hypertrophy model, ICaL was augmented in non-hypertrophic cells (Keung, 1989). It was 
thus suggested that ICaL could be increased before the cellular hypertrophy and then, as the 
cell grows, ICaL density would regain control values and even decrease in models of overt 
HF (Aimond et al., 1999; Benitah et al., 2002b). This process involves, at least partly, the 
cardiac mineralocorticoid pathway (Perrier et al., 2004; Benitah et al., 2010). Although most 
reports agree with the idea that ICaL density is normal in failing hearts, its kinetic seems to be 
significantly altered (Ryder et al., 1993; Bito et al., 2008). Thus, the decay of the whole-cell 
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ICaL and its CDI have been found to be slowed, causing a reduction in the peak of the [Ca2+]i 
transients producing less Ca2+-induced inactivation of ICaL. Thus, the maintained ICaL density 
together with a slowing of its inactivation would at the end increase the total account of Ca2+ 
entry through the channel (Aimond et al., 1999; Benitah et al., 2010). Such slowing of the 
decay of the current has a direct effect on the EC-coupling and is involved in the 
prolongation of APD favoring EADs observed in failing conditions (Tomaselli & Rose, 2000). 
An increase in Po and availability of LTCCs in human failing myocardium have been 
reported (Schröder et al., 1998), suggesting that the failing myocytes has fewer but more 
active channels. Hence, the response of ICaL to cAMP is reduced in ventricular myocytes 
from failing hearts (Chen et al., 2002). The attenuated increase of ICaL by ǃ-adrenergic 
stimulation is consistent with a reduction in the maximal number of channels, which have a 
higher activity (Bito et al., 2008). This is related to the concept of “defective EC coupling” in 
HF (Gómez et al., 1997): The failing myocytes had a significant reduction in triggered Ca2+ 
release from the SR despite unaltered ICaL, which could be due to structural alteration in the 
relation between LTCCs and ryanodine receptors, related to important structural changes as 
a loss of T-tubules density in human and experimental HF (He et al., 2001; Balijepalli et al., 
2003; Louch et al., 2004; Lyon et al., 2009; Horiuchi-Hirose et al., 2011). The increased basal 
activity at the single Ca2+ channel levels is also consistent with changes in the 
phosphorylation state of the channel. Thus, both increases in PKA and CaMKII-dependent 
phosphorylation of LTCC have been described in failing myocytes (Schröder et al., 1998; 
Chen et al., 2008; Wang et al., 2008). PKA activation through ǃ-adrenergic stimulation leads 
to increase ICaL, as well as the CaMKII-dependent phosphorylation of both pore-forming ǂ1C 
and ǃ2 subunits, which also increased ICaL CDF (Yuan & Bers, 1994; Hudmon et al., 2005; 
Grueter et al., 2006). In cardiac hypertrophy with prolongation of APD, these features are 
important since ICaL can be inappropriately reactivated and contribute to EADs triggered 
arrhythmia (Wu et al., 2002; Anderson et al., 2011). Moreover, Cavǃ2 expression is 
downregulated in the compensated phase of cardiac hypertrophy, while an upregulation is 
observed in failing states, which could explain the increase in the activity of LTCCs 
observed in single channel studies (Hullin et al., 2007).  
5. Inherited channelopathies or genetically determined ion-channel disorder 
The critical role of LTCCs in cardiac cells has led many to suggest that inherited defects of 
LTCCs could be incompatible with life. This view dramatically changed in the 2004 when 
the CaCNA1C gene was found to show genetic linkage to life-threatening arrhythmias 
associated with Timothy syndrome (Splawski et al., 2004). Since, we witnessed an explosion 
of information linking LTCC genes mutations (more than 25 mutations identified in the past 
decade) with a wide variety of inherited arrhythmia syndromes (Napolitano & Antzelevitch, 
2011). 
5.1 LQT8 or Timothy syndrome 
Identified in the 1990s (Marks et al., 1995), Timothy syndrome, or syndactyly-associated 
LQTS or LQT8, is a dominantly inherited genetic condition characterized by multisystem 
dysfunction, with severe arrhythmic disorders including: QT prolongation; 2:1 
atrioventricular block (due to delayed ventricular repolarisation); T-wave alternans, 
polymorphic VT, and TdP; and abnormal changes in multiple organs (heart, skin, eyes, 
teeth, immune system, brain, and dysmorphism, such as syndactyly). Patients with LQT8 
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may also have episodic hypoglycaemia, which can trigger arrhythmias, and structural heart 
anomalies, including patent ductus arteriosus, patent foramen ovale, ventricular septum 
defect, and tetralogy of Fallot. Prognosis is very poor and SCD often occurs during 
childhood. 
Gain-of-function mutations in CACNA1C, localized at the end of IS6 segment that is 
important for the regulation of channel inactivation and the binding of the Cavǃ subunit, 
have been associated with Timothy syndrome (Splawski et al., 2004; Splawski et al., 2005). A 
missense mutation G406R in the minor alternatively splice exon 8 of CACNA1C gene, as 
been first identified in all probands analysed (Splawski et al., 2004). Later, two other Gly 
mutations in the mutually exclusive major spliced exon 8a (G402S and G406R) were shown 
to cause a very similar syndrome but without the syndactyly (Splawski et al., 2005). These 
mutations exert powerful effect on inactivation, slowing the VDI irrespective of auxiliary ǃ 
subunits, while through a proposed low-Po gating shift speeding the kinetics of CDI (Barrett 
& Tsien, 2008), which was previously reported unchanged (Splawski et al., 2005). Moreover, 
the mutation did not affect closed-state VDI, which might explain absence of hypertension 
associated with LQT8, and along with impaired open-state VDI, slowed activation and 
deactivation (Yarotskyy et al., 2009). The later is in part consistent with spontaneous 
increased occurrence of mode 2 gating at single channel level, which has been associated 
with the generation of a consensus phosphorylation site for CaMKII (Erxleben et al., 2006). 
Indeed, on isolated rat cardiomyocytes infected with dihydropyridine-resistant G406R 
Cav1.2 channel, CaMKII autophosphorylation is increased, which mediated enhanced ICaL 
facilitation, AP prolongation, increased Ca2+ spark frequency and afterdepolarizations (Thiel 
et al., 2008). The impaired inactivation of LTCC leads to sustained Ca2+ influx, AP 
prolongation, and Ca2+ overload, which promotes EADs and DADs (Jacobs et al., 2006; 
Sicouri et al., 2007). Roscovitine, a compound that increases the VDI, rescues the 
electrophysiological and Ca2+ homeostasis properties of Timothy syndrome cardiomyocytes 
(Yazawa et al.). Ca2+ channel blockade (eg, by verapamil and diltiazem) can control 
arrhythmias without affecting the QT interval, and is a possible treatment (Napolitano et al., 
2006). 
5.2 ICaL and LQT syndrome 
The QT interval is an electrocardiographic index of ventricular repolarization and a measure 
of the duration of the ventricular AP. Ca2+ influx through LTCC plays a significant role in 
maintaining the plateau phase of AP and hence contributes importantly to APD and QT 
interval. Therefore, administration of CCB is a logical strategy in all types of LQTS. In the 
clinical study involving recording of monophasic AP (MAP) in eight patients with LQTS, 
verapamil effectively abbreviated MAP duration and suppressed epinephrine-induced 
EADs (Shimizu et al., 1995). At the bench side, verapamil effectively abbreviates QT interval 
and suppresses TdP in models of congenital and acquired LQTS (LQT1+ LQT2) (Aiba et al., 
2005). In a rabbit model of drug-induced LQT2, the  increased ICaL at the base of hearts, 
attributable to gender and regional difference in Cav1.2 expression, is an important 
determinant of the arrhythmia phenotype (Sims et al., 2008). This echoes clinical reports 
suggesting that Ca2+ channel antagonists might be appropriate as adjunctive therapy for 
arrhythmia suppression in LQT1, LQT2 and even LQT3 (Shimizu et al., 2005). Hence, an 
anti-arrhythmic effect of the specific LTCC antagonist nifedipine has been reported in mice 
with targeted disruption of the Na+ channel gene (Thomas et al., 2007), as well as in intact 
hearts from LQT5 mice model (Balasubramaniam et al., 2003). 
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5.3 J wave syndromes 
Because they share a common arrhythmic platform and similarities in ECG characteristics, 
clinical outcomes and risk factors, congenital and acquired forms of Brugada (BrS) and early 
repolarization (ERS) syndromes have been grouped together under the heading of J wave 
syndromes (Antzelevitch & Yan, 2010). Recent studies have implicated loss of function 
mutations in all 3 subunits of the cardiac LTCC in the generation and accentuation of 
electrocardiographic J waves associated with these syndromes (Antzelevitch et al., 2007; 
Cordeiro et al., 2009); (Burashnikov et al.). 
5.3.1 Short QT syndrome 
Although QT prolongation has long been known to increase the risk of SCD and overall 
cardiac mortality among patients with a variety of underlying etiologies, a shorter than 
normal QT interval could also be detrimental leading to the concept of a new clinical entity, 
the short QT syndrome, associated with AF and SCD (Gussak et al., 2000). Since more than 
30 patients with SQTS have been reported (Schulze-Bahr et al., 1997; Gaita et al., 2003; 
Schimpf et al., 2005; Giustetto et al., 2006). 
SQT4 and SQT5 are associated with mutations in CACNA1C and CACNB2B (Antzelevitch 
et al., 2007). These mutations reduce ICaL, shorten QT, and are associated with asymmetrical 
T waves, attenuated QT-heart rate relations, and AF. More recently, a new variant of SQTS 
at a heterozygous state caused by a mutation in the CACNA2D1 gene has been reported 
(Templin et al., 2011). This mutation leads also to a decreased ICaL, without modification in 
the Cav1.2 expression suggesting alteration of some of the biophysical single channel 
properties of channel. 
5.3.2 Brugada syndrome 
Brugada syndrome (BrS), an inherited cardiac arrhythmia syndrome associated with a 
relatively high risk of VF, was first described as a new clinical entity in 1992 (Brugada & 
Brugada, 1992). The ECG features of the Brugada patient includes an accentuated J wave 
displaying a real or apparent right branch bundle block and ST segment elevation in the 
right precordial leads. Although the BrS has thus far been linked to mutations that impede 
Na+ channel expression or function, alterations in ICaL current with CCBs have been 
implicated in the development of BrS both clinically (Shimizu, 2005) and experimentally 
(Fish & Antzelevitch, 2004). 
Recently, novel mutations of the cardiac LTCC genes responsible for shortening of the QT 
interval in families characterized by SCD, AF and a BrS type I ECG pattern have been 
reported (Antzelevitch et al., 2007). Functional analyses revealed loss-of-function missense 
mutations of the CACNA1C (A39V in the N-terminus and G490R in the I-II domain linker) 
and CACNB2 (S481L). These mutations reduce ICaL amplitude (due to trafficking defect for 
A39V), shorten QT, and are associated with asymmetrical T waves, attenuated QT-heart rate 
relations, and AF. Some patients also have tall, peaked T waves. These patients can also 
have BrS-type ST elevation in the right precordial leads with or without drug provocation, 
suggesting that the same reduction in ICaL underlies both SQTs and BrS. More recently, a 
novel missense mutation (T11L) in CACNB2B has been associated with BrS (Cordeiro et al., 
2009). Characterized in heterologous expression system, this mutation induced faster 
inactivation kinetics and hyperpolarized shift in the steady-state inactivation without any 
other alteration in ICaL, resulting in a reduced depolarizing current in response to epicardial 
AP waveform. 
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6. Current antiarrhythmic strategies and ICaL 
Current therapy to prevent cardiac arrhythmia is multidimensional and complicated. The 
conventional antiarrhythmic drugs have limited efficacy and safety. In the case of the most 
common cardiac arrhythmia, AF, treatment strategies can be pharmacological or 
interventional (e.g. catheter ablation techniques) but are also complicated by the presence of 
co-morbidities such as hypertension, diabetes, and/or pre-existing cardiovascular diseases 
(HF or coronary artery disease) (Prystowsky et al., 2010). Within the pharmacological 
strategies there are several groups of drugs including ǃ-blockers, angiotensin-converting 
enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), lipid-lowering and 
antithrombotic agents, spironolactone, among others, which have also demonstrated its 
efficacy in the prevention of SDC (Alberte & Zipes, 2003). From among all of them, the 
greatest reduction in cardiovascular mortality has been demonstrated with the treatment of 
ǃ-blockers (Dorian, 2005). However, these drugs most likely exert their antiarrhythmic 
potential indirectly by affecting “upstream events” that contribute to the development of 
electrophysiological instability (Rubart & Zipes, 2005). 
It has been demonstrated that the direct blockade of ICaL with dihydropyridine Ca2+ channel 
blockers (CCBs) produces a strong shortening in the APD. So, blocking ICaL is a potent 
means of suppressing VF. In Langendorff-perfused rabbit hearts, verapamil decreased the 
frequency of arrhythmia and changed it from disorganized VF into more organized VT 
(Samie et al., 2000). Similar results were also obtained using nifedipine (Choi et al., 2002). 
Therefore, CCBs could be considered promising antiarrhythmic drugs. However, the effects 
of these drugs have not emerged as unequivocally favorable in all clinical studies. Thus, 
verapamil and diltiazem can, in some cases, prevent episodes of acute ischemia VF in 
human, but they do not demonstrated to have as much of a beneficial effect on overall 
mortality as ǃ-blockers or angiotensin-converting enzyme (ACE) inhibitors (Bodi et al., 
2005). The problem observed with the direct blockade of ICaL using CBBs is that, at the same 
time that VT is prevented, the contractility could be suppressed, precluding their clinical 
usefulness as antifibrillatory drugs. Therefore, in the last years it has been proposed that 
only modifying ICaL kinetic properties, instead of blocking ICaL, could produce equivalent 
anti-fibrillatory effects without impairing EC coupling (Mahajan et al., 2008). 
In the clinical setting it is well established that the improvement in the current approach to 
treat AF is completely necessary. Amiodarone is the most effective antiarrhythmic drug for 
maintaining sinus rhythm in patients with AF. However, the extra-cardiac side effects have 
been a limiting factor, especially during chronic use, and may offset its benefits. 
Dronedarone is a new antiarrhythmic drug similar to amidarone that has been developed to 
provide rhythm and rate control in AF patients with fewer side effects. Dronedarone is 
considered as a potent blocker of multiple ion currents, including ICaL, and also exhibits 
antiadrenergic effects. In myocytes from several experimental animals, it has been 
demonstrated that the effect of dronedarone on ICaL consists in 76% block at dose of 10 µM 
with IC50=0.18 µM (Varró et al., 2001; Gautier et al., 2003). Dronedarone has also important 
antiarrhythmic effects. Intravenous administration of dronedarone shortened ventricular 
APD, suppressed EADs, ectopic beats and also TdP (Verduyn et al., 1999). Moreover, 
intravenous dronedarone was able to prevent VF in a rat model of ischemia and 
reperfusion-induced arrhythmias (Manning et al., 1995). Similarly, several clinical trials 
have demonstrated that dronedarone is able to maintain sinus rhythm and control 
ventricular rate in AF, reducing the number of cardiovascular hospitalizations and mortality 
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in patients with high-risk of AF (Singh et al., 2007; Davy et al., 2008; Hohnloser et al., 2009). 
The current DIONYSOS clinical trial has demonstrated that in a short-term, dronedarone 
was less effective than amiodarone in decreasing AF recurrence and maintaining normal 
sinus rhythm, but had a better safety profile, specifically with regard to thyroid and 
neurologic events and a lack of interaction with oral anticoagulants (Le Heuzey et al., 2010). 
However, the ANDROMEDA clinical trial has showed that dronedarone is also 
contraindicated in severe or deteriorating HF (Køber et al., 2008). The reason of that is 
because of a negative inotropic effect of dronedarone resulting from inhibition of ICaL that 
could have contributed to worsening of severe HF, increasing its mortality (Gautier et al., 
2003; Zimetbaum, 2009). Therefore, dronedarone is still under clinical studies and has to 
demonstrate its real antiarrhythmic potency and effectiveness over other antiarrhythmic as 
well as its possible effects in the management of additional arrhythmias, e.g. VT. 
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